Phase 1 Lymphoma, Non-Hodgkin's Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Follicular LymphomaLymphoma Diffuse Large B-cellLymphoma, Non-Hodgkin's

Eli Lilly and Company460 enrolled46 locationsNCT07226843

Recruiting

Phase 1Phase 2

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

High-grade B-cell LymphomaNon-Hodgkin LymphomaLymphoma+12 more

Estrella Biopharma, Inc.21 enrolled2 locationsNCT06343311